Algeria's Minister of Health, Mohamed Seddik Ait Messaoudene, and Derek O'Leary, Regional General Manager for India, Middle East, Turkey, and Africa at Boehringer Ingelheim, witnessed the signing of a cooperation agreement between the Ministry of Health and the German company. The agreement aims to support the Ministry's efforts in caring for stroke and rare diseases. The signing ceremony took place at the Ministry's headquarters on Thursday evening.
The agreement was signed by Souheila Lellou, Director of Therapeutic Programs and Medical Ethics at the Ministry of Health, and Samir Lahmaki, Managing Director of Boehringer Ingelheim Algeria. The agreement focuses on supporting and enhancing the capabilities of healthcare professionals and accompanying efforts to digitize the stroke care system. This aims to improve care pathways, enhance coordination among various stakeholders, and upgrade the quality of services provided to patients.
The agreement seeks to promote cooperation and partnership in public health by adopting an evidence-based approach. This approach allows for the evaluation of available resources and capacities, identification of priority needs, and development of suitable mechanisms to improve patient care. The Ministry of Health emphasized that this cooperation is part of its efforts to develop care pathways for priority diseases.
The cooperation aims to improve the quality of healthcare services, promote prevention, early diagnosis, and comprehensive care. This aligns with the needs of patients and supports the improvement of the national healthcare system's performance. The Ministry of Health is committed to developing care pathways for priority diseases and enhancing the quality of healthcare services.
The agreement with Boehringer Ingelheim is a significant step towards achieving the Ministry's goals. The partnership will focus on providing support and resources to enhance stroke and rare disease care in Algeria. The Ministry of Health is working to strengthen its partnerships with international organizations to improve the healthcare system.
The healthcare system in Algeria is working to address the challenges posed by stroke and rare diseases. The Ministry of Health is committed to providing high-quality care to patients and improving health outcomes. The agreement with Boehringer Ingelheim is expected to have a positive impact on the healthcare system in Algeria.
The Ministry of Health and Boehringer Ingelheim will work together to implement the agreement and achieve its objectives. The partnership is expected to enhance the quality of care provided to patients with stroke and rare diseases in Algeria.
Key points
- Algeria's Ministry of Health signs cooperation agreement with Boehringer Ingelheim to improve stroke and rare disease care.
- The agreement aims to support and enhance the capabilities of healthcare professionals and digitize the stroke care system.
- The partnership seeks to promote cooperation and partnership in public health by adopting an evidence-based approach.
